Clinical Trial Update: Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery [Phase 3]

View source ↗

Summary

A Phase 3 study in Japan evaluated the safety and efficacy of enoxaparin for patients undergoing hip fracture surgery. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Sanofi | Conditions: Hip Fractures | Phase 3 | Status: COMPLETED